Patient Characteristics Sorted by gB Type
| . | Type 1 or 2 . | Type 3 or 4 . |
|---|---|---|
| . | (n = 183) . | (n = 92) . |
| . | No. of Patients . | No. of Patients . |
| Diagnosis at transplant | ||
| ALL/remission | 10 | 7 |
| ALL/relapse | 16 | 6 |
| AML/remission | 20 | 14 |
| AML/relapse | 32 | 17 |
| Breast cancer | 2 | 0 |
| CML-Chronic phase | 34 | 17 |
| CML-Accelerated phase | 10 | 6 |
| CML-Second chronic phase | 3 | 0 |
| CML-Blast phase | 4 | 2 |
| HD | 3 | 0 |
| NHL/remission | 4 | 1 |
| NHL/relapse | 13 | 5 |
| MDS | 7 | 3 |
| MM | 2 | 1 |
| Other | 23 | 13 |
| Acute GVHD | ||
| ? | 7 | 3 |
| 0-I | 64 | 38 |
| II-IV | 112 | 51 |
| CMV disease | 116 | 52 |
| Patient/donor CMV serostatus | ||
| +/+ | 81 | 44 |
| +/− | 58 | 30 |
| −/+ | 20 | 6 |
| −/− | 8 | 3 |
| ? | 16 | 9 |
| Donor type | ||
| Auto | 10 | 6 |
| Matched | 120 | 49 |
| Mismatched related | 32 | 21 |
| URD | 21 | 16 |
| Median age | 34 | 31 |
| Number dead | 120 | 59 |
| Median day of death | 140 | 145 |
| Median day 1st + CMV culture | 78 | 83 |
| . | Type 1 or 2 . | Type 3 or 4 . |
|---|---|---|
| . | (n = 183) . | (n = 92) . |
| . | No. of Patients . | No. of Patients . |
| Diagnosis at transplant | ||
| ALL/remission | 10 | 7 |
| ALL/relapse | 16 | 6 |
| AML/remission | 20 | 14 |
| AML/relapse | 32 | 17 |
| Breast cancer | 2 | 0 |
| CML-Chronic phase | 34 | 17 |
| CML-Accelerated phase | 10 | 6 |
| CML-Second chronic phase | 3 | 0 |
| CML-Blast phase | 4 | 2 |
| HD | 3 | 0 |
| NHL/remission | 4 | 1 |
| NHL/relapse | 13 | 5 |
| MDS | 7 | 3 |
| MM | 2 | 1 |
| Other | 23 | 13 |
| Acute GVHD | ||
| ? | 7 | 3 |
| 0-I | 64 | 38 |
| II-IV | 112 | 51 |
| CMV disease | 116 | 52 |
| Patient/donor CMV serostatus | ||
| +/+ | 81 | 44 |
| +/− | 58 | 30 |
| −/+ | 20 | 6 |
| −/− | 8 | 3 |
| ? | 16 | 9 |
| Donor type | ||
| Auto | 10 | 6 |
| Matched | 120 | 49 |
| Mismatched related | 32 | 21 |
| URD | 21 | 16 |
| Median age | 34 | 31 |
| Number dead | 120 | 59 |
| Median day of death | 140 | 145 |
| Median day 1st + CMV culture | 78 | 83 |
Abbreviations: ALL, acute lymphocytic leukemia; CML, chronic myelocytic leukemia; HD, Hodgkin's disease; NHL, non-Hodgkin's lymphoma; MDS, myelodysplastic syndrome; MM, multiple myeloma; GVHD, graft-versus-host disease; URD, unrelated donor.